Form D · Biotechnology

NemaMetrix Inc.

Eugene, OR · CIK 0001651873

Offering snapshot reported Feb 27, 2019 · SEC filing

Reported sold
$5.16M
Offering amount: $6.55M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 8, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 27, 2019Initial$5,162,950No comparison8SEC filing
Apr 25, 2018Initial$1,550,000No comparison2SEC filing
Mar 14, 2017Initial$2,507,338No comparison23SEC filing
Apr 27, 2016InitialYet to sellNo comparison0SEC filing
Sep 14, 2015Initial$150,000No comparison1SEC filing
Sep 8, 2015Initial$20,561No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-333701

Source: Form D, filed Feb 27, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matt Beaudet Director, Executive
Trisha Brock Director
Ann Bunnenberg Director
Chris Carlson Director
Evangeline Gonzalez Director
Chris Hopkins Director
Shawn Lockery Director, Executive
Rick Miller Director
Kevin Padrick Director
Amy Tykeson Director
Janis Weeks Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
44 West 7 Th Avenue
Eugene, OR, 97401